Acadia Pharmaceuticals Inc. <ACAD.O>: UBS raises target price to $49 from $45
ACAD•Related News
Nasdaq Trade Halt <NUR.O> Volatility Trading Pause at 09:32 AM
NUR•
Nasdaq trade halt <STFS.O> volatility trading pause at 09:47 AM
STFS•
BMV suspends AvalonBay Communities shares on Global Market SIC Capitales after NYSE halt
AVB•
Canaan Inc. Provides July 2026 Bitcoin Production And Mining Operation Updates
CAN•
James River Group Holdings Inc <JRVR.O>: UBS cuts target price to $4.45 from $4.75
JRVR•